A family holding hands on a beach at sunset
Islamabad, Pakistan · MedVoyage Global Partner

Strive Foundation for SMA in Pakistan

A non-profit dedicated to Spinal Muscular Atrophy (SMA), and more widely to people living with disability from neurological and neuromuscular conditions. Strive works on access to treatment, awareness and advocacy, and earlier diagnosis and research. MedVoyage Global supports SMA families with specialist opinions and coordinated care.

Working on SMA since 2010 Independently auditedPrivate & confidential
About Strive

Founded by Someone Who Lives With SMA

Strive’s founder was diagnosed with SMA Type III in 1999, at a time when Pakistan had no treatment pathway for the condition. In 2010, together with friends, he set up Strive Trust and the Ibn-e-Sina Physiotherapy & Rehabilitation Center (IPRC) to raise awareness and give practical support.

After a decade, the rehabilitation centre closed so that Strive could concentrate on national and international collaboration to bring modern SMA treatments to Pakistan. That is the work Strive Foundation carries on today.

Vision

A future reimagined, where no disability limits the life we’re born to live.

Mission

To lead the transformation of healthcare and opportunity for people with disabilities.

Two hands reaching towards each other

“Curing the incurable is not just a slogan: it is our promise.”

Strive Foundation

What Strive Does

Three Pillars of Work for SMA

Strive’s work is organised around three areas, from getting treatments approved and available to finding SMA earlier and preventing new cases.

Treatment Access

From approvals to real-world access: getting therapies to the patients who need them.

  • Working to make globally recognised SMA therapies available in Pakistan
  • Strive reports that it enabled the local availability of an FDA-approved SMA therapy, risdiplam (Evrysdi)
  • Tracking treatment cycles for patients on nusinersen and risdiplam
  • Pushing for treatment to be affordable for families

Awareness & Advocacy

Making SMA visible, and making sure patients are heard where decisions are made.

  • Raising public awareness of SMA and other neuromuscular conditions
  • Meeting health authorities about SMA treatment coverage
  • Advocating for the registration of SMA treatments in Pakistan
  • Bringing families, doctors and supporters together with one voice

Diagnosis, Screening & Research

Finding SMA earlier, preventing new cases and building the evidence base.

  • Promoting early diagnosis and genetic testing
  • Carrier screening and genetic counselling for families
  • Working towards newborn screening protocols for SMA
  • A national SMA patient registry, using anonymised data
  • Research collaborations with Pakistani and international universities, and clinical trials
For SMA Families

How Strive Supports Families

Families can register with Strive. After a registration is reviewed and approved, a request for financial assistance towards treatment becomes possible. The process is built on medical verification, fair prioritisation and transparent management of funds.

  1. 01

    Register as a Patient

    Families register the person with SMA through Strive. A gene test report can be added at this stage, but it is optional.

  2. 02

    Review & Approval

    Strive reviews each registration, with medical verification of the diagnosis.

  3. 03

    Request Assistance

    Once a registration is approved, the family can submit a request for financial assistance towards treatment.

  4. 04

    Prioritised Fairly

    Requests are prioritised and funds are managed transparently. Whether support is given is Strive’s decision.

Governance and Accountability

Strive describes these safeguards on how it is run and how support is decided. Strive also runs a supporter membership, the Life Club, that helps fund treatment.

  • Independent statutory audit and audited accounts
  • Legal counsel
  • Patient-first policies
  • Ethical screening of support requests
  • A stated commitment to protect vulnerable patients from exploitation
Where MedVoyage Global Fits

Specialist Input for SMA Families

Strive works on access, advocacy and research in Pakistan. Alongside that, MedVoyage Global can help a family get clear medical input on their case, wherever the right specialist is.

Specialist Second Opinions

A specialist reviews the diagnosis, scans and test results, and gives an independent written view on the case and the options.

Online Consultations

Families can speak with doctors from our international network by video, without travelling.

Reports in Order

We help gather and organise medical reports, genetic test results and treatment history, so each doctor sees the full picture.

Care Abroad, If Needed

If a family is considering assessment or treatment in another country, we can coordinate the medical and practical side.

MedVoyage Global does not supply medicines, provide funding or take part in Strive’s decisions on registration or financial assistance.

Goals

What Strive Is Working Towards

These are Strive’s stated goals and pledges. They describe where Strive wants SMA care in Pakistan to be, not results already achieved.

Stated Goals

  • Government coverage of SMA treatment under national health programmes
  • A sustainable National SMA Treatment Fund
  • Treatment access for at least 75% of diagnosed SMA patients
  • SMA included in national newborn screening and rare-disease policies
  • A centralised national SMA registry
  • Fewer new cases, through genetic counselling, carrier screening and prenatal screening

Strive’s Pledges

  • Speed up approval and local availability of globally recognised therapies
  • Work towards treatment that families can afford
  • Collaborate with pharmaceutical companies on national clinical trials
  • Research alongside international institutions
  • Use AI to support better healthcare
  • Prevent the exploitation of vulnerable patients
Plainly Stated

What This Is, and Is Not

Here is where the boundaries sit, so your family can make decisions with the facts in front of you.

A Non-Profit, Not a Hospital

Strive Foundation is a non-profit organisation. It does not diagnose or treat patients. Medical care is provided by doctors and hospitals.

Treatment Is a Doctor’s Decision

SMA therapies are prescribed by a treating neurologist. Eligibility depends on the type of SMA, age and a medical assessment.

Financial Support Is Not Guaranteed

Any financial assistance is decided by Strive after its own verification and review. Neither Strive nor MedVoyage Global can promise funding.

We Do Not Supply Medicines

MedVoyage Global does not sell, import or supply medicines. Availability of each therapy in Pakistan can change.

No Outcome Is Guaranteed

SMA treatments affect each person differently, and no doctor can guarantee a particular result.

Not for Emergencies

If someone has trouble breathing or another urgent problem, contact your local emergency services immediately.

Questions

What SMA Families Ask

If your question is not here, ask us directly. Answers about treatment always depend on the person, so a doctor needs to see the reports.

This page gives general information only. It is not medical advice.

SMA is an inherited genetic condition that affects the nerve cells in the spinal cord that control movement. This leads to muscle weakness and wasting, which can affect sitting, walking, swallowing and breathing. It is usually caused by changes in the SMN1 gene, and a child is affected when both parents pass on a changed copy. SMA is grouped into types depending on when symptoms begin and how severe they are, and it can vary a great deal from person to person.

Strive’s registration is for people with SMA and their families. A gene test report can be included but is optional at registration. Each registration is reviewed by Strive before it is approved. If you would like help with the next step, contact MedVoyage Global.

Once a registration is approved, families can request financial assistance towards treatment. Requests go through medical verification and prioritisation, and the decision is Strive’s alone. Support is not guaranteed, and MedVoyage Global has no say in it.

Three disease-modifying treatments are approved in many countries: nusinersen (Spinraza), given as an injection into the spinal fluid; risdiplam (Evrysdi), taken by mouth every day; and onasemnogene abeparvovec (Zolgensma), a one-time gene therapy given into a vein, generally for young children. Physiotherapy, breathing and nutrition support are also important. Which treatment is suitable depends on the person, and availability in Pakistan varies, so this is a conversation to have with a neurologist.

We can arrange a specialist second opinion on the diagnosis and treatment options, set up an online consultation with a doctor from our network, and help organise reports and genetic test results so they are ready for each doctor. If treatment abroad is being considered, we can coordinate that too. We do not supply medicines or provide funding.

Strive’s work is focused on Pakistan. MedVoyage Global works with families in many countries, so specialist second opinions and online consultations are available wherever you are.

Yes. Reports you share with MedVoyage Global are seen only by the doctors involved in your case, and only for your care. Strive states that its national patient registry uses anonymised data.

Get a Specialist’s View on Your Child’s or Your Own SMA

Send us the diagnosis, genetic test results, doctor’s notes and current treatment: clear phone photos are fine. We will arrange the right specialist to review them and explain the next steps.

All enquiries about Strive Foundation through this website are handled by MedVoyage Global. Strive Foundation is a non-profit organisation, not a hospital or clinic. Financial assistance is decided by Strive after its own review and is not guaranteed. Nothing on this page is medical advice, a diagnosis or a promise of a particular outcome. Not for medical emergencies.

Chat with us